Jackson ImmunoResearch, a manufacturer of secondary antibodies and immunoreagents for the life science market, announces a ...

Anti-amyloid antibodies lecanemab and donanemab are in clinical use now, but that does not mean research on them has stopped. At the Clinical Trials on Alzheimer’s Disease conference, held October ...